Related Experiment Video
Updated: Jun 15, 2026
09:07
A Human Bone Marrow 3D Model to Investigate the Dynamics and Interactions Between Resident Cells in Physiological or Tumoral Contexts
Published on: December 16, 2022
2.9K
Advances in microfluidic biofabrication technology for bone metastasis modeling.
Mehdi Khanmohammadi1, Nima Ahmadkhani2, Marina Volpi1
1Biomaterials Group, Materials Design Division, Faculty of Materials Science and Engineering, Warsaw University of Technology, Wołoska 141, Warsaw 02-507, Poland.
Biofabrication
|May 15, 2025
Summary
Three-dimensional (3D) microfluidic models offer a more accurate way to study bone metastasis than traditional 2D cultures. These advanced models improve drug screening and understanding of cancer cell interactions in bone.
Area of Science:
- Biomedical Engineering
- Cancer Research
- Microfluidics
Background:
- Studying bone metastasis is crucial for developing effective cancer therapies.
- Traditional 2D cell cultures do not accurately mimic the 3D bone microenvironment, leading to disparities in drug response and biological behavior.
- There is a need for more biomimetic models to study cancer cell interactions with bone tissue.
Purpose of the Study:
- To review recent advancements in microfluidic-based 3D bone metastasis models.
- To examine innovative applications of microfluidic technology in bone metastasis research and drug discovery.
- To discuss the benefits and limitations of these models for treating bone metastases.
Main Methods:
- Development of microfluidic-based 3D cancer models, including organ-on-chip platforms.
- Utilizing hydrogel-based biofabrication for spherical and filament structures.
- Implementation of various drug screening techniques on-chip, such as concentration gradient generators and microdroplet arrays.
Main Results:
- Microfluidic 3D models effectively replicate complex cell-cell and cell-extracellular matrix interactions in the bone microenvironment.
- These models provide more biologically relevant data compared to 2D cultures.
- Innovative applications include 2D/3D tumor-on-a-chip systems and specialized drug screening chips.
Conclusions:
- Microfluidic-based 3D bone metastasis models represent a significant advancement over traditional methods.
- These platforms enhance the screening of potential therapeutics and deepen the understanding of bone metastasis mechanisms.
- Further development of microfluidic platforms holds great promise for future drug discovery in oncology.
